Is this the next wearable tech trend?

CGMs have revolutionised diabetes care since the first device was approved in 1999, offering patients a way to monitor their glucose levels continuously without the need for frequent fingerstick tests. The technology has improved significantly since then, becoming more accurate, user-friendly and integral to the management of type 1 diabetes, and increasingly important for many type 2 diabetics as well. So what's next for market growth and investment opportunities? Peter Hughes, Redwheel Life Changing Treatments Strategy explores.